Skip to main content

Advertisement

Fig. 3 | BMC Gastroenterology

Fig. 3

From: Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice

Fig. 3

MSCs alleviated chronic colitis-associated hepatobiliary disorders. The DSS + vehicle group showed more severe hepatobiliary disorders compared to that of the control group, while MSCs ameliorated hepatobiliary disorders associated with chronic colitis. a Representative sections samples of liver (H&E and MT staining; original magnifications, × 200). b Histological score (aP < 0.05 vs. the DSS + vehicle group; bP < 0.05 vs. the control group). c, d Liver function, ALT and AST levels in the DSS + vehicle group were increased and ALB level were lowered compared to that of the control group. ALT and AST levels in the DSS + MSCs group were significantly lower and ALB levels were increased (aP < 0.05 vs. the DSS + vehicle group; bP < 0.05 vs. the control group). TBIL and DBIL levels were not changed (aP > 0.05 vs. the DSS + vehicle group; bP > 0.05 vs. the control group). Data were expressed as mean ± SD

Back to article page